Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: 777 Captain who wrote (17076)	12/20/1998 8:57:00 PM
From: alan laValley	Read Replies (1) \| Respond to of 23519

For what it's worth Vivus latest "cash or cash available" from Yahoo Financial cash............................................4,690,000 Available for sale securities..................13,516.000 Available for sale securities (non-current .....7,301,000 total cash......25,507,000 Future income from milestone payments...........8,000,000 total cash......33,507,000 debt.....................0

To: 777 Captain who wrote (17076)	12/20/1998 11:15:00 PM
From: VLAD	Read Replies (2) \| Respond to of 23519

Captain, With the current level of overhead drastically reduced Vivus can cover its expenses and at least show a slight profit. That doesn't matter. We need to see quarters of profits of at least .10 not including milestone money. The milestone money is nice but it is a one time event. After Vivus gets the $8M for Europe and $2M for China, I am unaware of any other milestone agreements. Income from product sales is what we want to see ASAP. I believe Vivus should beat the -.03 estimate for Q4 (I think we might even see a slight profit). We probably can get a good idea on Q1 '99 just from Q4 figures and IMS data on domestic sales.